Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ronald Scott

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|July 23, 2002
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher RegistryNeal J Weinreb, Joel Charrow, Hans C Andersson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 20, 2020
Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spotsXinying Hong, Jessica Daiker, Martin Sadilek, et al.
The Journal of Pediatrics|December 13, 2016
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and ManagementLorne A Clarke, Andrea M Atherton, Barbara K Burton, et al.
The Journal of Pediatrics|January 15, 2004
Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendationsJoel Charrow, Hans C Andersson, Paige Kaplan, et al.
Journal of Genetic Counseling|July 5, 2015
Genetic Counseling and Screening of Consanguineous Couples and Their Offspring: Recommendations of the National Society of Genetic CounselorsRobin L Bennett, Arno G Motulsky, Alan Bittles, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2005
Individualization of long-term enzyme replacement therapy for Gaucher diseaseHans C Andersson, Joel Charrow, Paige Kaplan, et al.
Molecular Genetics and Metabolism|May 31, 2016
Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass SpectrometrySusan Elliott, Norman Buroker, Jason J Cournoyer, et al.
Data in Brief|August 11, 2016
Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: By tandem mass spectrometrySusan Elliott, Norman Buroker, Jason J Cournoyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2017
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendationsJeffrey M Chinsky, Rani Singh, Can Ficicioglu, et al.
American Journal of Hematology|June 2, 2017
Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher RegistryPramod K Mistry, Julie L Batista, Hans C Andersson, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|July 23, 2002
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher RegistryNeal J Weinreb, Joel Charrow, Hans C Andersson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 20, 2020
Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spotsXinying Hong, Jessica Daiker, Martin Sadilek, et al.
The Journal of Pediatrics|December 13, 2016
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and ManagementLorne A Clarke, Andrea M Atherton, Barbara K Burton, et al.
The Journal of Pediatrics|January 15, 2004
Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendationsJoel Charrow, Hans C Andersson, Paige Kaplan, et al.
Journal of Genetic Counseling|July 5, 2015
Genetic Counseling and Screening of Consanguineous Couples and Their Offspring: Recommendations of the National Society of Genetic CounselorsRobin L Bennett, Arno G Motulsky, Alan Bittles, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2005
Individualization of long-term enzyme replacement therapy for Gaucher diseaseHans C Andersson, Joel Charrow, Paige Kaplan, et al.
Molecular Genetics and Metabolism|May 31, 2016
Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass SpectrometrySusan Elliott, Norman Buroker, Jason J Cournoyer, et al.
Data in Brief|August 11, 2016
Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: By tandem mass spectrometrySusan Elliott, Norman Buroker, Jason J Cournoyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2017
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendationsJeffrey M Chinsky, Rani Singh, Can Ficicioglu, et al.
American Journal of Hematology|June 2, 2017
Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher RegistryPramod K Mistry, Julie L Batista, Hans C Andersson, et al.
Pageof 9